famotidine
NDC 68475-400, famotidine, powder, for suspension, from Navinta LLC.
- Product NDC
- 68475-400
- Status
- Listed
- Labeler
- Navinta LLC
- Dosage form
- POWDER, FOR SUSPENSION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA091020
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/68475-400 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- FAMOTIDINE40 mg/5mL
Pharmacologic classes
Histamine H2 Receptor Antagonists [MoA]; Histamine-2 Receptor Antagonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 68475-400-01 | 68475040001 | 50 mL in 1 BOTTLE, PLASTIC (68475-400-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/0f34a3be-7554-4040-b808-5ba8bf064abc
Use it
Look up 68475-400 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/68475-400 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 68475-400. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.